跳至主要内容
临床试验/ISRCTN12833814
ISRCTN12833814已完成未知

Effects of Bergamot (Citrus bergamia Risso et Poiteau) and wild cardoon (Cynara cardunculus L.) extract intake on non-alcoholic fatty liver disease (NAFLD)

Italian Ministry of University and Research (MIUR)0 个研究点目标入组 102 人开始时间: 2019年8月7日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
102

研究概览

简要总结

2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32849284/ results (added 02/09/2020) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36556930/ (added 06/09/2023)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Over 30 years old
  • 2. Both genders
  • 3. Liver steatosis defined by CAP score over 216 dB/m

排除标准

  • 1. Past and current alcohol abuse
  • 2. Clinical and laboratory signs of chronic hepatitis B and/or C virus infection
  • 3. Allergies to cardoon, artichoke or maize
  • 4. Triglycerides concentration over 250 mg/dl
  • 5. Autoimmune or cholestatic liver disease
  • 6. Liver cirrhosis
  • 7. Pregnancy
  • 8. Nephrotic syndrome
  • 9. Chronic renal failure
  • 10. Gastroesophageal reflux
  • 11. Cancer
  • 12. Taking amiodarone, antiretroviral agents, corticosteroids, methotrexate, tamoxifen, valproate. The study's protocol allowed to enrol only long-term lipid-lowering drugs users (more than 6 weeks)

研究者

发起方
Italian Ministry of University and Research (MIUR)

相似试验